144 related articles for article (PubMed ID: 18055095)
1. Early onset vulvar Lichen Sclerosus in premenopausal women and oral contraceptives.
Günthert AR; Faber M; Knappe G; Hellriegel S; Emons G
Eur J Obstet Gynecol Reprod Biol; 2008 Mar; 137(1):56-60. PubMed ID: 18055095
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of topical progesterone versus topical clobetasol propionate in patients with vulvar Lichen sclerosus - A double-blind randomized phase II pilot study.
Günthert AR; Limacher A; Beltraminelli H; Krause E; Mueller MD; Trelle S; Bobos P; Jüni P
Eur J Obstet Gynecol Reprod Biol; 2022 May; 272():88-95. PubMed ID: 35290878
[TBL] [Abstract][Full Text] [Related]
3. Topical testosterone versus clobetasol for vulvar lichen sclerosus.
Ayhan A; Guven S; Guvendag Guven ES; Sakinci M; Gultekin M; Kucukali T
Int J Gynaecol Obstet; 2007 Feb; 96(2):117-21. PubMed ID: 17239881
[TBL] [Abstract][Full Text] [Related]
4. Progestogens with antiandrogenic properties.
Raudrant D; Rabe T
Drugs; 2003; 63(5):463-92. PubMed ID: 12600226
[TBL] [Abstract][Full Text] [Related]
5. A double-blind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosus.
Goldstein AT; Creasey A; Pfau R; Phillips D; Burrows LJ
J Am Acad Dermatol; 2011 Jun; 64(6):e99-104. PubMed ID: 21353334
[TBL] [Abstract][Full Text] [Related]
6. Management of sexual dysfunction due to vulvar lichen sclerosus in postmenopausal women.
Pinelli S; D'Erme AM; Lotti T
Dermatol Ther; 2013; 26(1):79-82. PubMed ID: 23384025
[TBL] [Abstract][Full Text] [Related]
7. Open-label trial of cyclosporine for vulvar lichen sclerosus.
Bulbul Baskan E; Turan H; Tunali S; Toker SC; Saricaoglu H
J Am Acad Dermatol; 2007 Aug; 57(2):276-8. PubMed ID: 17442452
[TBL] [Abstract][Full Text] [Related]
8. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
Dinger J; Assmann A; Möhner S; Minh TD
J Fam Plann Reprod Health Care; 2010 Jul; 36(3):123-9. PubMed ID: 20659364
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of the therapeutic effects of oral contraceptive pills containing desogestrel, cyproterone acetate, and drospirenone in patients with polycystic ovary syndrome.
Bhattacharya SM; Jha A
Fertil Steril; 2012 Oct; 98(4):1053-9. PubMed ID: 22795636
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, randomized prospective study evaluating topical clobetasol propionate 0.05% versus topical tacrolimus 0.1% in patients with vulvar lichen sclerosus.
Funaro D; Lovett A; Leroux N; Powell J
J Am Acad Dermatol; 2014 Jul; 71(1):84-91. PubMed ID: 24704090
[TBL] [Abstract][Full Text] [Related]
11. The treatment of vulvar lichen sclerosus and female sexual dysfunction.
Burrows LJ; Creasey A; Goldstein AT
J Sex Med; 2011 Jan; 8(1):219-22. PubMed ID: 20955314
[TBL] [Abstract][Full Text] [Related]
12. Testosterone versus clobetasol for maintenance of vulvar lichen sclerosus associated with variable degrees of squamous cell hyperplasia.
Ayhan A; Guven ES; Guven S; Sakinci M; Dogan NU; Kucukali T
Acta Obstet Gynecol Scand; 2007; 86(6):715-9. PubMed ID: 17520405
[TBL] [Abstract][Full Text] [Related]
13. Presenting Symptoms and Diagnosis of Vulvar Lichen Sclerosus in Premenopausal Women: A Cross-Sectional Study.
Krapf JM; Smith AB; Cigna ST; Goldstein AT
J Low Genit Tract Dis; 2022 Jul; 26(3):271-275. PubMed ID: 35533256
[TBL] [Abstract][Full Text] [Related]
14. Characteristics Among Premenarchal Girls With Lichen Sclerosus.
Wang M; Arlen AM; Vash-Margita A
J Low Genit Tract Dis; 2021 Apr; 25(2):152-157. PubMed ID: 33284147
[TBL] [Abstract][Full Text] [Related]
15. Vulvar lichen sclerosus: effect of maintenance treatment with a moisturizer on the course of the disease.
Simonart T; Lahaye M; Simonart JM
Menopause; 2008; 15(1):74-7. PubMed ID: 17603391
[TBL] [Abstract][Full Text] [Related]
16. An arm-based network meta-analysis on treatments for vulvar lichen sclerosus and a call for development of core outcome sets.
Pergialiotis V; Bellos I; Biliou EC; Varnava P; Mitsopoulou D; Doumouchtsis SK;
Am J Obstet Gynecol; 2020 Jun; 222(6):542-550.e6. PubMed ID: 31697910
[TBL] [Abstract][Full Text] [Related]
17. The course of lichen sclerosus diagnosed prior to puberty.
Focseneanu MA; Gupta M; Squires KC; Bayliss SJ; Berk D; Merritt DF
J Pediatr Adolesc Gynecol; 2013 Jun; 26(3):153-5. PubMed ID: 23507004
[TBL] [Abstract][Full Text] [Related]
18. Childhood lichen sclerosus: a long-term follow-up.
Patrizi A; Gurioli C; Medri M; Neri I
Pediatr Dermatol; 2010; 27(1):101-3. PubMed ID: 20199428
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life and patient-defined benefit of clobetasol 0.05% in women with chronic lichen sclerosus of the vulva.
Schwegler J; Schwarz J; Eulenburg C; Blome C; Ihnen M; Mahner S; Jaenicke F; Augustin M; Woelber L
Dermatology; 2011; 223(2):152-60. PubMed ID: 21997592
[TBL] [Abstract][Full Text] [Related]
20. The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia.
Panidis D; Georgopoulos NA; Piouka A; Katsikis I; Saltamavros AD; Decavalas G; Diamanti-Kandarakis E
Gynecol Endocrinol; 2011 Aug; 27(8):587-92. PubMed ID: 20836726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
